abstract |
The present invention relates to a polyoxomolybdate-bisphosphonate complex containing a bisphosphonate ligand, wherein it further contains a heterometallic ion different from molybdenum, for use in treating cancer. n It further relates to novel polyoxomolybdate-bisphosphonate complexes containing a bisphosphonate ligand, wherein it further contains a heterometallic ion different from molybdenum, to their preparation process and pharmaceutical composition containing them. |